The traditional diagnostic and evaluative methods for patients with HF and CKD, which rely on serum creatinine or Brain Natriuretic Peptide (BNP) levels, are limited as they reflect changes in only one organ at a time. This evidence concerns the gene NPPB and hydrops fetalis.